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Abstract.  Osteocalcin, also called Bone Gla Protein 
(BGP), is the most abundant of the non-collagenous 
proteins of bone produced by osteoblasts. It consists of 
a  single chain of 46-50 amino acids, according to the 
species, and contains three vitamin K-dependent 
gamma-carboxyglutamic acid residues (GLA), involved 
in its binding to calcium and hydroxylapatite. Ac- 
cumulating evidences suggest its involvement in bone 
remodeling,  its physiological role, however, is still un- 
clear.  In this study the adhesion properties and the 
biological effects of osteocalcin on osteoclasts have 
been analyzed using as an experimental model, human 
osteoclast-like cells derived from giant cell tumors of 
bone (GCT).  Osteocalcin promoted adhesion and 
spreading of these cells, triggering the release of bone 
sialoprotein (BSP), osteopontin (OPN) and fibronectin 
(FN), that in turn induced the clustering in focal adhe- 
sions of fl~ and/33 integrin chains.  Spreading was de- 
pendent upon the synthesis of these proteins.  In fact, 
when the cells were incubated in the presence of 
monensin during the adhesion assay,  they still adhered 
but spreading did not occur, focal adhesions disap- 
peared and BSP, OPN, and FN were accumulated in 
intracellular  granules.  Furthermore osteocalcin in- 
duced chemotaxis in a dose-dependent manner.  The 
action of BGP on osteoclasts was mediated by an in- 
tracellular calcium increase due to release from thap- 
sigargin-sensitive stores.  These results provide evi- 
dences that BGP exerts a  role in the resorption 
process, inducing intracellular  signaling,  migration and 
adhesion,  followed by synthesis and secretion of en- 
dogenous proteins. 
STEOCALCIN, alSO called Bone Gla Protein (BGP), ~ 
is the most abundant of the non-collagenous  proteins 
of bone produced by osteoblasts, and has several in- 
teresting  features.  It consists  of a  single  chain  of 46-50 
amino acids,  according to the species,  and contains three 
vitamin K-dependent gamma-carboxyglutamic  acid residues 
(GLA), involved in its binding to calcium and hydroxylapa- 
tite (19, 33). So far, BGP has been considered highly specific 
for bone, secreted by mature osteoblasts, and incorporated 
into the extracellular  matrix.  Recently, it has been demon- 
strated that the mouse genome contains an osteocalcin clus- 
ter composed of three genes (34, 13). The first two, named 
OG1 and OG2, are expressed only in bone, while the third 
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one, the osteocalcin-related  gene ORG, is transcribed in the 
kidney,  where a protein similar  to ostecalcin had already 
been described and called nephrocalcin  (13). Despite its high 
degree of conservation between species and its specificity for 
bone tissue, the physiological  role of osteocalcin is still not 
very clear. Accumulating  evidences suggest that osteocalcin 
is involved in bone remodeling.  A potential role of this pro- 
tein in the induction  of bone resorption has been suggested 
by in vitro experiments  showing that it has chemotactic ac- 
tivity for a number of cells including monocytes which are 
known  to be related to osteoclast precursor cells (25, 28, 
29). Experimental rat models in which animals were main- 
tained on high doses of warfarin  in order to deplete their 
bone of osteocalcin, have shown impaired recruitment and 
differentiation of osteoclast-like  cells by these bone implants 
(10, 14). Other experiments  using  this  model have further 
suggested that osteocalcin might function as a matrix signal 
in the recruitment and differentiation of bone resorbing ceils 
(15, 31). 
Osteoclasts,  the multinucleated  giant cells present in bone, 
are the effectors of bone resorption (39, 41). The resorptive 
process  involves  proliferation  of developing  osteoclasts, 
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tion onto the bone matrix. When osteoclasts polarize, a seal- 
ing zone of close adhesion between their apical membrane 
and bone is formed, thereby isolating the ruffled border area 
where resorption takes place (21, 39, 41). Membrane recep- 
tors of the integrin family and RGD-containing bone matrix 
proteins are  known to be  involved in the adhesion of os- 
teoclasts to the bone surface (35, 36, 37, 42), while the mech- 
anism of osteoclast recruitment to. the resorption sites re- 
mains very elusive. 
In this paper, we present data indicating a specific relation 
between osteocalcin and osteoclasts. We show that osteocal- 
cin induces chemotaxis, calcium-mediated intracenular sig- 
nals, and secretion of matrix proteins by osteoclast-like cells, 
obtained from giant cell tumors of bone (GCTs), character- 
ized for their osteoclast features  (16). 
Materials and Methods 
Cell Cultures 
Osteoclast-like cells were isolated from biopsy specimens of human GCTs, 
after a patient's informed consent at the Istituti Ortopedici Rizzoli as already 
described (16). Briefly, cells were mechanically dispersed with a Pasteur pi- 
pette, or, alternatively, released by a 30-rain digestion with 2 mg/ml Clos- 
tridium  Histolyticum  neutral collagenase (Sigma Chem. Co., St.  Louis, 
MO) in PBS (in raM: 138 NaC1, 2.7 KC1, 0.9 Na2HPO4,  1.4 KH2PO4, pH 
7.3).  Released cells were plated in 25 cm  2 Falcon flasks (Oxuard, CA) at 
a density of 10,000 cells/cm  2 and cultured in Iscove medium supplemented 
with 10% FCS (Gibeo Limited, Uxbridge, UK), 100 IU/ml penicillin, 100 
/~g/ml streptomycin, 2.5 #g/ml amphotericin B and 50 IU/ml mycostatin 
(Eurobio, Paris, France), at 37°C, in a water-saturated atmosphere with 5 % 
CO2.  Cells were fed by medium replacement every 2-3 d. 
The osteoclastlc phenotype of cultured cells has been extensively studied 
and published elsewhere (16). Briefly, GCT cell morphology was observed 
by phase contrast microscopy and the number of nuclei per cell, as well as 
the number of multlnucleated vs mononuclear cells, were evaluated. Bind- 
ing of calcitonin on cells previously incubated for 3 h in the presence of 
1/~Ci/ml 125I-human calcitonin (Amersham, UK) was investigated by au- 
toradiographic technique, cAMP production in cells incubated in 1BMX- 
buffer and treated for 10 rain with 10  -7 M calcitonin was measured using 
the Incstar Corporation (Stillwater, MN) radioimmunoassay. Bone resorp- 
tion was biochemically detected incubating GCT cells for 48 h in the pres- 
ence of [3H]proline in vivo prelabeled bone particles, in control conditions 
or in the presence of 10  -7 M calcitonin, as described by Blair et al.  (3). 
Bone resorption was also morphologically evaluated according to Arnett 
and Dempster (1), by analysis of pits escavated by cells plated onto bone 
slices. 
Proteins 
Bovine carboxylated and  decarboxylated osteocalcin,  was  purified and 
decarboxylated as described previously (26). Plasma fibronectin (FN) was 
from Sigma Chem. Co. The synthetic peptides GRGDSP (Gly-Arg-Gly- 
Asp-Set-Pro) and GRGESP (Gly-Arg-Gly-Glu-Ser-Pro) peptides were pur- 
chased from Telios (La Jolla, CA). 
Preparation and Coating of  Glass Coverslips 
Glass coverslips (12 mm in diam) were cleaned by immersion in nitric acid 
for 3 h, in water for 1 h, and in ethanol for another hour, and then dried 
and sterilized before use. The coverslips were coated with 200 #1 of os- 
teocalcin or FN (20 and 10 ~g/ml, respectively) in PBS containing 1 mM 
CaC12, for 15-20 h  at 4°C.  Residual protein-binding sites on coverslips 
were saturated by further incubation (30 rain, room temperature [RT]) in 
a buffer containing 1% BSA (fatty acid free, Sigma Chem. Co.). Coverslips 
were then washed three times with Iscove medium plus 0.5% BSA. 
Antibodies 
In this report, we used a set of antibodies recognizing the/~1  and ~3 inte- 
grin subunits, cellular fibronectin, bone sialoprotein (BSP), and osteopon- 
tin (OPN).  /~t antibodies were MAR4 (32),  a mouse mAb for immuno- 
staining, and a previously described goat anti-fibronectin receptor (8) used 
for adhesion assays; /33 antibodies were rabbit polycloual serum against 
platelet GpHIa (11), mAb IST-9 to the extra domain (ED) specifically ex- 
pressed by cell-assembled FN and not by plasma FN (4,  5) was kindly 
provided by Dr. L. Zardi (Istituto Scientifico per 1o Studio e la Cura dei 
Tumori, Genova, Italy). BSP was immunolocalized by a polyclonal anti- 
body raised against bovine BSP as described previously (7), by a polycioual 
antibody, LF-6, raised against human BSP, as well as with LF83 and LFI00 
raised against synthetic sequences of human BSP; OPN was detected by a 
polyclonal antibody LF-7 raised against human OPN. LF6, LF7, LF83, and 
LF100 were all kindly provided by Dr. P.  Gehron-Robey and by Dr.  L. 
Fisher (National Institute of Dental Research, National Institutes of Health, 
Bethesda, MD). Antibodies raised against bovine osteocalcin  were provided 
by Dr. C. Cbenu. The localization of vinculin was assayed with mAb VIN 
11-5 to chicken gizzard vinculin and cross-reacting with the mammalian 
form (Sigma Chem. Co.). 
Adhesion and Spreading  Assays 
GCT cells were grown in 25 cm  2 flasks; at confluence, cells were tryp- 
sinized and resuspended in Iscove containing 0.5% BSA at a concentration 
of 20000 cells/ml and 1 ml of cell suspension was seeded on each coated 
coverslip. Aliquots of cells were also resuspended in Iscove containing 10 
#g/ml Monensin (Mon) (Sigma Chem. Co.), and seeded on coated cover- 
~lips. 
After 6 h of incubation at 37°C, coverslip-attached cells were washed 
three times with Ca2+Mg  2+ PBS and fixed in 3 % paraformaldehyde, 2 % 
sucrose in PBS pH 7.6 for 10 rain at RT. After rinsing in PBS, cells were 
permeabilized to antibodies by  soaking coverslips for 3  rnin at 0°C in 
Hepes-Triton X-100 buffer (20 mol/L Hepes, Ph 7.4, 300 mol/L sucrose; 
50 mol/L NaC1;  3  mol/L MgC12; and 0.5%  Triton X-100,  from Sigma 
Chem. Co.). This procedure of fixation and permeabilization has been used 
for other studies of cytoskeleton and adhesion (12). 
Adhesion assays were performed on 96-well microtiter plates coated 
overnight with 20/~g/mi of proteins (see above) and on uncoated wells. Ex- 
periments were performed in a serum-free medium, containing 0.5% BSA. 
Cells plated on uncoated wells in the presence of serum were used as posi- 
tive controls. After trypsinization, cells were counted, diluted at a density 
of 2.5  ×  lOS/ml, and 200 #1 of GCT cell suspension were placed in each 
microtiter well for 6 h in a humidified atmosphere containing 95 % air and 
5 % CO2.  Non-adhering cells were removed by gently washing the wells 
three times with PBS. Adherent cells were fixed with 3 % paraformaldehyde 
for 20 rain at RT, followed by rinsing with PBS, air-dried and stained with 
0.5% crystal violet for 15 rain, followed by extensive rinsing. The dye was 
released from the cells by addition of Na-citrate 0.1 M in 50% ethanol. The 
optical  density  of the  released  stain  solution  was  read  in  a  Titertek 
colorimeter at 540 rim. Results were expressed as percentage +  SE of the 
absorbance read in control samples. A  group of experiments were per- 
formed for a shorter time (60 min) with or without 200 ~g/ml GRGDSP 
or GRGESP peptides in the medium. To investigate the adhesion inlubitory 
effect of integrin antibodies, similar experiments were performed, with anti- 
~t and anti-~3 antibodies added to the cell suspension at the time of plating 
at different dilutions, in the presence or absence of monensin. In the same 
conditions, the competitive effect of 20  #M  osteocalcin in the culture 
medium during adhesion assay to osteocalcin-coated wells was evaluated. 
Fluorescence Studies 
Indirect immunofluorescence was used to show the topography of integrins 
and matrix molecules. The primary antibody was layered on fixed and per- 
meabilized cells and incubated in a humidified chamber for 45 min at 37°C. 
After rinsing in PBS (pH 7.6), coverslips were incubated with the appropri- 
ate  rhodamine-tagged secondary antibody  (Dako-patts,  Glostrup,  Den- 
mark) for 45 rain at 37°C. After rinsing in PBS, coverslips were incubated 
with 25 #g/ml fluorescein-labeled phalloidin (F-PHD, from Sigma Chem. 
Co.) for 45 min at 37°C. Coverslips were then mounted in 20%  Mowiol 
4-88  (HOECHST  AG,  Frankfurt/Main,  FGR).  Observations were per- 
formed by epifluorescence in a Zeiss Universal microscope. Fluorescence 
images were recorded on Kodak T-Max 400 films and developed in a Kodak 
T-Max developer for 10 min at 20°C. 
Measurement of Cytosolic Calcium Concentration 
Cytosolic free calcium concentration in response to addition of BGP was 
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(Sigma Chem. Co.). Isolated cells seeded onto 24-mm diana round glass 
coverslips were loaded with 10t~M fura-21AM in serum free, but otherwise 
complete, IMDM  for  1 h  at 37"C.  Coverslips were washed three times 
and transferred to a  Sykes Bellco open chamber (Bellco Biotechnology, 
Vineland, NJ) containing 1 ml Krebs-Ringer-Hepes  buffer (KRH) (in raM: 
125 NaCI, 5 KC1, 1.2 KH2PO4,  1.2 MgSO4, 2 CaC12,  265 Hepes, and 6 
glucose).  [Ca2"~]i-dependent  fluorescence was  measured  with  a  micro- 
fluorometer (Cleveland Bioinstrumentation,  Cleveland,  OH)  connected 
with a Zeiss IM35 inverted microscope equipped with a Nikon CF X40 fluor 
objective. Recordings were performed at dual excitation wavelength (340 
and 380 nm, bandwidth 0.5 nm) using an air turbine high-speed rotating 
wheel carrying the two excitation falters. Emission was collected by a pho- 
tomultiplier carryirig a 510-nm cutoff  filter and analyzed by a demodulator. 
Emission from 340 and 380 run and real-time 340-380 nm ratio were re- 
corded by a Linseis L6514 recorder. At the end of  each experiment, calibra- 
tion was performed by adding 5 #M ionomycin followed by 7.5 mM EGTA 
to obtain Ca2+-saturated and nominally Ca2+-free  fura-2 fluorescence, re- 
speetively. Thapsigargin (Sigma Chem. Co.) was used to deplete intracellu- 
lar pools. [Ca2+]i was calculated according to Grynkiewicz et al.  (18). 
Chemotaxis Assay 
Chemotaxis activity of  BGP was determined in vitro with the Boyden cham- 
ber technique (28). Briefly,  the osteoclast-like cells (150,000  cells/500 #i) 
were  seeded in  the upper  compartments of modified Boyden chambers 
(Costar Corp., Cambridge, MA) and osteocalcin at different concentrations 
(2  x  10  -6 M to 6  x  10 --6 M) was added in the lower compartments. Both 
the cells and osteocalcin were diluted to the desired concentration in IMDM 
1% serum. The compartments were separated by polycarbonate membranes 
(Nucleopore, Costar Corp.) with pores of 8 #m in diameter. The chambers 
were incubated for 5  h  at  370C  in a  5%  CO2/95%  water-saturated at- 
mosphere, cells attached to the upper side of the filter were mechanically 
removed while cells that had migrated to the lower side were fixed with 3 % 
paraformaldehyde in cacodylate buffer, stained in 0.5% Crystal Violet and 
lysed in 0.1 N sodium citrate to read the absorbance at 540 nm. Negative 
control was medium alone. Controls with osteocalcin added in the upper 
compartment on the cell side of  the membrane were also performed. Three 
chambers were used for each treatment and final activity was expressed as 
mean  +  SEM of triplicates. 
Statistic Analysis 
Quantitative data are expressed as average +  SEM. Statistic analysis was 
performed by Student's t test. 
Figure 1. Phase contrast microscopy of  cells from a giant cell tumor 
of bone (GCT24) in culture at the 8th passage. Multinuclear  and 
mononuclear  cells are present.  Bar, 40 #m. 
nin. These features have been extensively described and dis- 
cussed in reference (16).  The shape shown by the cells in 
culture is variable. Mononuclear cells are usually polygonal, 
elongated or macrophage-like, while multinuclear contain a 
variable number of nuclei (2-12) and present rounded edges, 
more similar to bona fide osteoclasts (Fig.  1). The possible 
presence of contaminating cells of different phenotype has 
been excluded by the absence of alkaline phosphatase-posi- 
tive cells, absence of collagen fibrils in the culture as well 
as by the homogeneous integrin pattern in control conditions 
and when GCTs were plated on different substrata (17). 
Adhesion of GCT Cells onto BGP 
When GCT cells were plated onto 20 #g/ml BGP-coated cov- 
Results 
Cell Characterization 
Human osteoclast-like cells obtained from giant cell tumors 
of bone were used in passages between VII and XI. The os- 
teoclast phenotype of the cells used for the experiments has 
been extensively characterized and recently published else- 
where  (16).  They consist  of homogeneous  lines  (GCT23, 
GCT24) derived from tumors in which the transformed cell 
was in the osteoclastic lineage. These cells keep dividing in 
vitro and polycarions derive both from fusion or endomyto- 
sis  (16).  The  percentage  of mononuclear vs multinuclear 
cells is inversely related to the division rate of the cell line 
(28  +  2 multinuclear in GCT23, 72  +  1 in GCT24). In all 
the experiments performed (16, 17,  30),  differences in be- 
havior between mononuclear and multinuclear cells were not 
found.  TRAP  activity was both histochemically  and  bio- 
chemically detected.  Calcitonin receptors were present on 
the membrane of all the cells, independently from the num- 
ber of nuclei and cAMP content was doubled by calcitonin 
treatment. Bone resorption was evident both by pit assay and 
by [3H]proline-prelabeled bone particles degradation.  Re- 
sorption was significantly reduced in the presence of calcito- 
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Figure 2. Adhesion onto osteocalcin of cells obtained from human 
giant cell tumors of bone. The adhesion assay was performed plat- 
ing cells on wells coated with osteocalcin 20 #g/ml, FN 10 #g/ml 
or uncoated in the presence of serum or BSA as positive and nega- 
tive controls,  respectively. In some experiments,  the  GCT cells 
were  maintained  for  three  weeks  in  the  presence  of  10  -s  M 
1.25(OH)2VitD3 before the assay. The number of attached cells is 
expressed as percentage of the adhesion obtained  in the presence 
of serum. Results represent the mean  +  SE of three experiments 
performed in triplicate.  Ligand abbreviations: FCS, medium con- 
taining  10% FCS;  BSA, bovine serum albumin;  FN, fibronectin; 
BGP, osteocalcin. 
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of  the cells attached to BGP (Fig. 2). A similar adhesion was 
noted on coverslips coated with fibronectin but, while most 
of  the cells spread onto fibronectin, spreading onto BGP was 
less pronounced. Absence of cell adhesion resulted in wefts 
coated with BSA as a negative control. The positive control 
was FCS. When the GCTs were maintained continuously for 
three weeks in the presence of 10  -8 M  1.25(OH)~  vitamin 
D3, their capability of adhesion to BGP lost while they still 
adhered  onto  fibronectin.  This  could  indicate  that  more 
differentiated osteoclasts  may not  recognize this  protein, 
while less mature cells as they are in this tumor population, 
can recognize BGP. The cells adhered in the same way to 
decarboxylated BGP indicating that cell attachment was not 
related to electrostatic interactions between the cells and the 
highly negative charges of GLA residues contained in this 
protein. Furthermore the adhesion in both cases was not in- 
hibited by the presence of RGD-containing peptides (data 
not shown). Cation effect on adhesion was also assayed plat- 
ing  the  cells  in  the  presence of EGTA  (3  mM),  but  no 
changes were found (not shown).  When adhesion experi- 
ments were performed in the presence of  monensin, the cells 
attached, but spreading was inhibited (Fig. 3). The competi- 
tive presence of 20 gM osteocalcin in the culture medium 
produced a reduction of 35 % from control adhesion values 
when monensin was also present,  while no changes were 
found without monensin (not shown). 
Figure  3. GCT cells plated onto osteocalcin in the absence of serum 
and fixed after 3 h. Cells are adherent and spread (a). In the pres- 
ence of monensin (b) the cells maintain a rounded shape. Bar, 
50 gm. 
Cytoskeletal Organization and lntegrin Expression of 
GCT Cells Plated onto BGP 
Cytoskeletal organization and integrin expression of cells 
plated onto osteocalcin were analyzed by immunofluores- 
cence using antibodies directed against cytoskeletal proteins 
and integrins. Actin microfilaments were detected organized 
in stress fibers at the edge of which vinculin was clustered 
in focal adhesions (Fig. 4, a  and b). The presence of focal 
adhesions suggested the involvement of integrins, and, using 
monoclonal antibodies directed against the/~ and/33 inte- 
grin chains, we demonstrated a strong positive staining of  the 
cells  for these  subunits.  /33  was  found clustered  in  focal 
adhesions at the edge of the stress fibers (Fig. 4, c and d), 
while/31  was organized both along stress fibers and in focal 
adhesions (Fig. 4, e and f). The presence of organized focal 
adhesions and integrins in osteoclasts adherent to osteocal- 
cin was somehow unexpected, as this protein does not con- 
tain any known adhesive sequence. As a consequence we in- 
vestigated if GCT cells were synthesizing proteins which 
could allow their spreading through interactions with inte- 
grin receptors. We searched for the presence of fibronecfin, 
BSP, and osteopontin using antibodies directed against these 
proteins. Cellular fibronectin has been previously shown to 
interact in these cells with ot,/33 and ash/t,  while BSP and 
osteopontin bind to ot4~3 (6,  9,  17, 20, 27). We found that 
fibronectin was indeed secreted by the cells and organized in 
an  extracellular network of filaments matching  the  stress 
fiber organization under the basal cell membrane (Fig. 5 a). 
BSP and osteopontin were also present but with a different 
pattern.  BSP was detected inside the cells,  distributed in 
granules crowded at the proximity of cell surfaces, suggest- 
ing a  secretory activity (Fig.  5  b),  while osteopontin was 
clearly extracellular with a granular distribution under the 
focal adhesion sites (Fig. 5, c and d). If cells were occasion- 
ally detached during the staining procedure, granules were 
still found on the coverslips also if the cell was lacking (Fig. 
5, e and f). When the cells were incubated in the presence 
of  10  gg/mi  monensin  during  the  adhesion  assay,  their 
spreading on osteocalcin was not completed (Fig. 3), focal 
adhesions were absent and actin was mainly organized in a 
thin fibrillar network with only a  few fibers (Fig. 6 a). ~/~ 
and/~3 integrins were diffuse (Fig. 6, c and d), fibronectin, 
BSP,  and osteopontin appeared distributed in intracellular 
granules (Fig. 6, e and f). These results suggest that com- 
plete spreading  and  integrin organization were dependent 
upon new  protein  synthesis  during the adhesion process. 
Using antibodies against osteocalcin, a homogeneous stain- 
ing of the coverslips could be detected and we could observe 
that after cell adhesion the protein was endocytosed, leaving 
a typical dark pattern in the sites where cells were or had 
been attached (not shown). 
Chemotactic Activity of  Osteocalcin 
Towards GCT Cells 
A chemotactic role of  osteocalcin has been already suggested 
in literature (25,  28, 29) but has never been tested directly 
on osteoclastic cells. We studied the chemotactic activity of 
osteocalcin using modified Boyden chamber technique. Fig. 
7 shows the effects of various osteocalcin doses on migration 
of GCT cells in the presence of 1% FCS. A significant migra- 
tion of the cells at concentrations varying from 2/~M to 6 
The Journal of Cell Biology,  Volume 127, 1994  1152 Figure 4. Actin microfilament distribution,  vinculin localization,  and integrin expression were studied by indirect immunofluorscence in 
osteoclast-like cells from giant cell tumors of bone cultured 6 h onto osteocalcin-coated coverslips. Actin (a, c, and e) was organized in 
stress fibers at the edge of which vinculin (b) was immunostalned,  localized in focal adhesions./~3 integrin chain was immunostained, 
clustered  in focal adhesions  (d), while/~l  chain (f) was present both along stress fibers and in focal adhesions.  Bar, 20 #m. 
#M  with a  maximum effect already reached at 3  #M  was 
found. The specificity of the response was established using 
medium alone supplemented with 1% of serum as a negative 
control. Experiments were also performed adding osteocal- 
cin at the same concentrations on the cell side of the Boyden 
chambers  and  resulted  in  lack of migration  (not  shown). 
These results were reproducible in separate experiments. 
Effects of Osteocalcin on [Ca2+]l 
To understand the nature of the osteocalcin induced intracel- 
lular signals, we investigated the effect of osteocalcin addi- 
tion on cytosolic free calcium concentrations. As shown in 
Fig.  8 a,  [Ca2+]i in basal conditions was  140  +  19 riM, a 
value similar to what is observed in a number of cell types. 
Osteocalcin addition at a concentration of 10 #g/ml, induced 
an increase of [Ca~+]i peaking at 283  +  38 riM, which re- 
mained stable several minutes thereafter, followed by a  re- 
turn  to a  resting condition  higher than the previous basal 
level. Such a response was observed in all the cells tested. 
Fig.  9  illustrates the dose response curve, testing addition 
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proteins was demonstrated for 
osteoclast-like cells from gi- 
ant cell tumors of  bone. Cellu- 
lar  fibronectin  (a)  was  im- 
munodetected  by  a  specific 
antibody organized in an ex- 
tracellular network under the 
basal  membrane. BSP  was 
localized in granules crowded 
at  the  proximity of the  cell 
surface,  suggesting a  secre- 
tory pathway (b). Osteopontin 
was clearly extracellular with 
a granular distribution under 
stress fibers and focal adhe- 
sions (c, F-PHD; d, anti-osteo- 
pontin). If a cell had been oc- 
casionally detached during the 
staining procedure osteopon- 
tin granules were still present 
(f), while the corresponding 
cell was lacking in the same 
field  stained for  actin with 
F-PHD  (e).  Bar, 20/~m. 
from 10 ttg/ml to 100 #g/ml of BGP on [Ca2+]i of the cells. 
The response was found to be dose dependent with a maxi- 
mal  increase  already  observed  at  a  concentration  of 20 
#g/ml, which remained stable upon addition of 80 #g/ml of 
BGP and declined as BGP approached a  concentration of 
100 #g/ml.  The increase of [Ca2+]i induced by BGP could 
be  either  due  to  a  Ca  2÷  influx through the  plasma mem- 
brane or to a Ca  :+ release from intracellular stores (38). To 
study the mechanisms by which BGP influenced [Ca2+]i, we 
used thapsigargin, a tumor promoter known to activate the 
release  of Ca  2+  from intracellular  stores.  After treatment 
with  thapsigargin at 4  #M,  BGP failed to modify [Ca2+]~ 
(Fig.  8 b), suggesting that the osteocalcin effect on calcium 
concentration was mainly due to release from intracellular 
stores.  The role of extracellular  calcium was investigated 
performing the experiments in a medium containing 3 mM 
EGTA. In these conditions, BGP increased [Ca2+]i, but cal- 
cium levels after a few minutes returned to the baseline indi- 
cating that the increase was dependent upon the release of 
calcium from intracellular  stores,  while the plateau phase 
was  maintained  by  the  entrance  of extracellular  calcium 
(Fig.  8 c). 
Discussion 
The results reported in this paper indicate that osteocalcin 
acts as a specific signal from the bone matrix for migration 
and adhesion of human osteoclasts and that intracellular cal- 
cium acts as a  second messenger in this system. 
Osteoclast-like cells, obtained from GCTs, used for these 
experiments represent a valid model as they present most of 
the characteristics of human osteoclasts, as multinucleation, 
tartrate resistant acid phosphatase activity,  calcitonin recep- 
tors and ability of resorbing bone (16).  They are at present 
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were plated  onto osteocalcin 
in  the  presence  of  monen- 
sin.  Focal adhesions  were ab- 
sent, and actin,  detected  with 
F-PHD, was diffused or orga- 
nized in a  few  fibers  (a).  /~1 
(c) and/~3  (d) integrins  were 
diffused.  Fibronectin (b),  os- 
teopontin  (e),  and  BSP  (f) 
were distributed  in intracellu- 
lax  granules.  Integrins  and 
matrix proteins  were detected 
by  indirect  immunofluores- 
cence  with  specific  antibod- 
ies.  Bar,  20 #m. 
o 
o 
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Figure 7. Chemotactic activity of  osteocalcin toward osteoclast-like 
cells was measured by the modified Boyden chamber technique. 
Different concentrations (2-6/zM) of osteocalcin in Iscove medium 
containing 1% FCS were seeded in the lower compartment of the 
chambers, and  1.5  x  105 GCT cells,  in the same medium, were 
seeded in the upper compartments. The chambers were incubated 
for 5  h  at 37°C in a 5%  CO2/95%  water-saturated  atmosphere. 
the  only  available  model  for  human  osteoclasts  in  vitro, 
nevertheless their transformed origin should be remembered 
in evaluating the obtained results. 
Osteoclasts resorb bone by a complex process which im- 
plies their migration to the bone surface, adhesion to the ma- 
trix,  followed by polarization  and  organization  of sealing 
zone  and  ruffled  border,  allowing  the  resorption  process 
to take place.  Because of the impaired resorption of osteo- 
calcin-deficient bone particles,  osteocalcin has been specu- 
lated to be one of the putative signals arising from the bone 
matrix,  affecting osteoclast recruitment and differentiation 
(10,  14,  15, 31). While osteocalcin was previously shown to 
Cells attached to the upper side of the filter were mechanically re- 
moved, while cells that had migrated to the lower side were fixed 
with 3% paraformaldehyde in cacodylate buffer,  stained  in 0.5% 
Crystal Violet and lysed in 0.1 N sodium citrate to read the absor- 
bance at 540 rim. Negative control was medium alone. Three cham- 
bers were used for each treatment and final activity was expressed 
as mean  +  SE of triplicates. 
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Figure 8. The effect of osteocalcin on intracellular calcium concen- 
tration was determined in fura-2 loaded single GCT cells. Cells 
were equilibrated in Krebs-Ringer-Hepes buffer (KRH) for 10 min 
at 37"C, and then 20/~g/ml of BGP was added (arrows). [Ca2÷]i- 
dependent fluorescence was measured with a microfluorometer. 
Osteoealcin produced an increase in cytosolic calcium, followed  by 
a plateau which lasted several minutes (a).  [Ca2+]i elevation in- 
duced by BGP was abolished in cells preincubated with 4 ~M thap- 
sigargin, an inhibitor of endoplasmic reticulum Ca2+-ATPase (b), 
while experiments performed in Ca2+-free buffer by adding 3 mM 
EGTA (c) showed the absence of the plateau phase. 
be chemotacric for a number of cell lines (25,  28, 29), this 
is the first study that demonstrates a chemotactic activity of 
osteocalcin towards osteoclast-like cells, confirming that it 
may represent a component of bone matrix involved in the 
mechanism for attraction of the osteoclasts to the bone sur- 
0  /  i  t  t  t 
0  20  40  80  80  100  120 
BOP ~ml 
Figure 9. Dose dependence of [Ca2+]i increase elicited by osteocal- 
cin. Results represent the differences from average basal level after 
addition  of growing concentration  of osteocalcin.  Each  value 
represents the mean of six determinations  +  SE. 
face. Osteocalcin was effective  in increasing migration of  the 
GCT cells at the same concentration range effective in the 
chemotaxis of monocytes in previous study (28, 29). 
In this study, we have shown that osteoclast-like cells at- 
tach and spread on coverslips coated with osteocalcin. Other 
authors  (20)  were  not  able  to  find  similar  results,  their 
studies, however, differ in two respects. They used freshly 
isolated osteoclasts from different species, while our cells 
derived from human bone tumors. Moreover, our cells are 
not completely differentiated, as they still maintain mitotic 
activity. It is well possible that only less mature osteoclasts 
react chemotacrically to osteocalcin. This is confirmed by 
the fact that treatment with vitamin D3, a known differen- 
flaring agent, causes complete loss of osteocalcin recogniz- 
ing capability. It is interesting to remark that this was the 
only detectable effect after vitamin D  treatment, all other 
parameters of osteoclast differentiation and activity being 
unmodified. 
This is not the first example of cell adhesion to a member 
of the vitamin K-dependent protein family.  Previous cell 
adhesion to matrix Gla protein (MGP), has been already ob- 
served using different cell lines (24). Cell adherence to MGP 
nevertheless was inhibited by RGD-containing peptides and 
was requiring intact Gla residues. Our results show no differ- 
ence in cell adhesion using decarboxylated osteocalcin, sug- 
gesting that the cell recognition site is not containing the Gla 
residues. 
The presence of/3, and/33 integrins on GCT cells adher- 
ing to BGP suggests that full spreading, but not adhesion to 
osteocalcin, may depend upon new protein synthesis during 
the assay.  Experiments using  cycloheximide or monensin 
during the adhesion assay have shown that the number of 
GCT cells attached to BGP was not affected by the presence 
of inhibitors of protein synthesis and secretion. In addition, 
attachment of GCT cells to BGP was not dependent on RGD 
sequence as RGD-containing peptides did not inhibit cell 
adhesion.  Nevertheless,  monensin  almost  completely in- 
hibited the spreading of ceils on BGP and integrin clustering 
in focal adhesions was lacking under these conditions. These 
data suggest that spreading on BGP was dependent on pro- 
teins synthesized and secreted by GCT cells. Two adhesive 
proteins of the bone matrix, BSP and osteoponfln, have been 
recently shown to be expressed by osteoclasts (2, 40), and 
GCT cells are known to release FN when adhering to various 
substrata (17). Our results demonstrated positive staining of 
GCT cells plated onto BGP for BSP, OPN, and FN using ap- 
propriate antibodies, indicating secretion of these proteins 
by osteoclast-like ceils from giant cell tumors. This secretion 
in turn induced the recruitment in focal adhesions of/9, and 
/93 integrins.  These results were confirmed by treatment of 
cells with monensin which induced arrest of the secretion 
pathway and concentration of BSP, OPN, and FN in intracel- 
lular granules. Specific recognition of and adhesion by GCT 
cells to osteocalcin seems therefore  to occur in various steps. 
Attachment of the  cells  occurs  via  an  RGD-independent 
mechanism, this step is followed by a generation of intracel- 
lular signals that ends via an unknown cascade in the nu- 
cleus,  inducing synthesis and secretion of matrix proteins 
that finally allow spreading via an RGD-dependent mecha- 
nism, due to the release by the cells of RGD-containing pro- 
teins. We do not know if osteocalcin is recognized via an un- 
known integrin receptor, but it is unlikely, since the presence 
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out any effect and integrins require cations to be effective. 
Competition  experiments  with  ostex~alcin  in  the  culture 
medium during  the  adhesion  assays  significantly  reduced 
adhesion only in the presence of monensin. This finding is 
easily explained by the fact that osteocalcin induces synthesis 
and secretion of other proteins that affect osteoclast adhesion 
and spreading  via integrin chains. It is possible that protein 
secretion, without monensin, is induced both in cells that en- 
counter osteocalcin on the coated surface or in solution, and 
is  followed  by  full  spreading,  while  in  the  presence  of 
monensin these proteins are not released and competitive in- 
hibition can be found. 
The signals generated in ceils upon binding to osteocalcin 
have been studied. Changes in cytosolic Ca  2÷ are known to 
occur in cells upon recognition of some extracellular matrix 
proteins (22, 23, 27).  We have shown that BGP stimulates 
an increase of [Ca2+]i in GCT cells attached to glass cover- 
slips.  Similar  specific  increases  of  [Ca~÷]i  have  been 
demonstrated in GCT cells in response to OPN,  BSP and 
related fragments (30), but while these RGD-containing pro- 
teins  were inducing  a prompt,  transient  response,  the in- 
crease of [Ca2÷]~ due  to  osteocalcin  was  less pronounced 
and lasting longer before return to the baseline. To establish 
the  mechanism  causing  this  increase  in  [Ca2+]i, we have 
tested whether the effect was depending  upon Ca  ~+ influx 
through plasma membrane or upon release from thapsigar- 
gin-sensitive  intracellular  pools.  As  shown,  BGP  did  not 
significantly affect the  [Ca2+]i after thapsigargin  treatment. 
On the contrary  [Ca2÷]~ was also increased in the cells by 
BGP after addition of the Ca2+-chelaring agent EGTA, indi- 
caring the provenance of Ca  2+ from intracellular stores. 
In conclusion, this study provides evidences that osteocal- 
cin, a specific protein of the bone matrix, exerts a role in the 
resorption process,  including  migration  of osteoclasts  to- 
ward the bone matrix,  specific adhesion and intracellular 
signaling, followed by synthesis and secretion of proteins as 
osteopontin and BSP.  These bone matrix proteins,  recog- 
nized via ¢xv/33, have been suggested as putative inducers of 
cell polarization and bone resorption. It is possible that their 
secretion plays a role in osteoclast functions, contributing  to 
osteoclast "homing" in the bone matrix, when they reach the 
site where chemotactic stimula were originated. 
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